LivingGLP1
Study S000287

Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome

Registration

Registration
NCT02483299
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
NONE
Status
COMPLETED
Enrollment
40
Start
2014-01
Primary completion
2015-04
Lead sponsor
University Medical Centre Ljubljana
Conditions
PCOS; Obesity
Interventions
DRUG:Metformin; DRUG:Glucophage tablets and Victoza
Results posted
FALSE

Registered primary outcomes

  • Change in body weight [up to 12 weeks of clinical trial]
  • The number of good responders to combined treatment regarding body weight [up to 12 weeks of clinical trial]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.